According to the FDA’s own published research, dissatisfaction with vision after LASIK sits at just 1% to 4% — real numbers, not the vague “FDA says it’s safe” reassurance most articles rely on. Those numbers come from the FDA’s LASIK Quality of Life Collaboration Project, run with the National Eye Institute and Department of Defense, and its published PROWL-1 and PROWL-2 studies — including the specific detail that, across 574 real participants, exactly one person lost two or more lines of vision. This guide walks through the actual data, including the less flattering numbers most clinic content leaves out, and what the FDA’s role in LASIK safety actually covers.
Key Takeaways
- The real FDA source is the PROWL-1 and PROWL-2 studies — published in JAMA Ophthalmology, not a vague “FDA guidelines” reference.
- Dissatisfaction with vision at 3 months was 1–4%, and dissatisfaction with the surgery itself was just 1–2%.
- 43–46% of previously symptom-free patients developed at least one new visual symptom — a real number most competitor content omits entirely.
- Only 1% of participants had visual symptoms severe enough to interfere with daily activities.
- The FDA approves the laser devices used, not individual surgeons or clinics — and in 2022 proposed stronger patient labeling, including a decision checklist still pending finalization.
- More than 95% of participants reached 20/20 or better binocular uncorrected vision at 3 months.
What “FDA Data on LASIK” Actually Refers To
In October 2009, the FDA launched the LASIK Quality of Life Collaboration Project (LQOLCP) with the National Eye Institute and Department of Defense, specifically to measure how often patients develop real problems after LASIK — not just clinical outcomes, but symptoms and satisfaction as patients themselves report them. That project produced two studies: PROWL-1, following 262 active-duty Navy personnel for 6 months, and PROWL-2, following 312 civilians for 3 months. The combined results were published in JAMA Ophthalmology in 2017. When an article cites “FDA data on LASIK complications” without naming this project, it’s very likely paraphrasing secondhand — this is the actual primary source.
The Real Numbers, Verified
| Measure | Finding |
|---|---|
| Dissatisfaction with vision at 3 months | 1% to 4% of participants |
| Dissatisfaction with the surgery itself | 1% to 2% of participants |
| Visual symptoms “very” or “extremely” bothersome | Up to 4% of participants |
| Difficulty with or inability to do usual activities due to visual symptoms | Up to 1% of participants |
| Binocular uncorrected vision of 20/20 or better at 3 months | More than 95% of participants |
| Participants who lost 2+ lines of best-corrected vision (either study, any follow-up point) | 1 participant, out of 574 total |
Source: Eydelman et al., “Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With LASIK (PROWL) Studies,” JAMA Ophthalmology, 2017 — an FDA/NEI/DoD collaborative study.
The Number Most Competitor Content Leaves Out
Here’s the part that gets consistently omitted from clinic marketing content, including the version of this page you may have seen elsewhere: 43% of PROWL-1 participants and 45–46% of PROWL-2 participants who had no visual symptoms before surgery reported at least one new symptom — glare, halos, starbursts, or double images — at follow-up. That’s a real, substantial number, and leaving it out isn’t just incomplete, it undermines the credibility of citing “FDA data” at all.
The honest context that belongs alongside it: the overall prevalence of these symptoms actually decreased after surgery, because many participants who had bothersome symptoms before LASIK — often related to their uncorrected refractive error — improved or resolved entirely. And critically, only a small fraction of the new-symptom group found it severely bothersome: up to 4% rated symptoms as very or extremely bothersome, and just 1% reported real interference with daily activities. Our guide on how long halos typically last after LASIK goes deeper into that specific symptom if it’s your main concern.
What Each Number Actually Means for You
| If You’re Wondering… | The Relevant Data |
|---|---|
| “How many people regret getting LASIK?” | 1–4% reported dissatisfaction with their vision at 3 months |
| “Will I get halos or glare I didn’t have before?” | Nearly half of symptom-free patients developed at least one new symptom, though most rated it mild |
| “Could LASIK actually damage my vision?” | 1 participant out of 574 lost 2+ lines of best-corrected vision across both studies |
| “Will dry eye be a long-term problem?” | Up to 30% of previously dry-eye-free participants developed new dry eye symptoms by 3 months — our guide on how common dry eye actually is after LASIK covers this specifically |
What FDA Oversight of LASIK Actually Involves
Worth clarifying directly, since it’s commonly misunderstood: the FDA approves the laser devices used in LASIK as medical devices, through clinical trial data submitted by equipment manufacturers — between 2009 and 2021 alone, the FDA approved more than 115 refractive laser systems for LASIK through its most rigorous device pathway, premarket approval (PMA). It doesn’t license individual surgeons, certify specific clinics, or inspect every procedure — that oversight sits with state medical boards and professional certification bodies. “FDA-approved” tells you the laser platform met device-safety standards in trials; it doesn’t tell you anything about the specific surgeon performing your procedure. That distinction matters when you’re evaluating a clinic, and it’s exactly why candidacy screening and surgeon experience carry as much weight as the technology itself. Genuinely serious complications — the kind that threaten vision rather than just cause bothersome symptoms — remain rare in the published data; our guide on whether LASIK can cause blindness addresses that specific, worst-case question directly.
The FDA’s 2022 Patient Labeling Guidance — Still Pending
Something worth knowing that essentially no competitor content mentions: in July 2022, the FDA issued draft guidance proposing new, more detailed patient labeling requirements for LASIK devices, including a “patient decision checklist” designed to be reviewed with your surgeon before surgery. As of the FDA’s most recent published guidance priorities, this remains in draft status — not yet finalized — following nearly 700 public comments during its review period.
| What the Proposed Checklist Would Cover | Purpose |
|---|---|
| Who is a good candidate for LASIK | Plain-language contraindications and risk-increasing pre-existing conditions |
| What to expect before, during, and after surgery | Realistic expectations, not just the reassuring version |
| A summary of long-term risks | Presented in plain language with illustrative images of visual symptoms |
Source: FDA draft guidance, “Laser-Assisted In Situ Keratomileusis (LASIK) Lasers – Patient Labeling Recommendations,” issued July 27, 2022.
Until finalized, this isn’t a binding requirement — but it reflects the FDA’s own current thinking on what patients should see before consenting to surgery, and a clinic that already discusses these points openly is doing more than the current minimum, not less.
Bottom Line
The actual FDA-sourced data on LASIK is more specific, and more balanced, than the vague reassurance most articles offer: dissatisfaction rates of 1–4%, real but usually mild new visual symptoms in nearly half of previously symptom-free patients, and vision-threatening outcomes in roughly 1 out of every 574 study participants. That’s a genuinely different — and more useful — picture than either “LASIK is completely risk-free” or “LASIK is dangerous,” and it’s worth knowing the real numbers rather than a marketing summary of them.
Want to know how your own eyes and risk factors line up against this data? book a consultation at Visual Aids Centre — a proper screening tells you where you personally fall, not just the study averages.
Frequently Asked Questions
What is the actual LASIK complication rate according to the FDA?
The FDA’s PROWL studies (JAMA Ophthalmology, 2017) found 1–4% dissatisfaction with vision at 3 months, and 1 vision-threatening outcome (2+ lines lost) across 574 total participants.
Do a lot of people develop new symptoms like halos after LASIK?
Yes, a meaningful number — 43–46% of previously symptom-free patients reported at least one new visual symptom, though most rated it mild rather than severely bothersome.
Does FDA approval mean my specific surgeon is vetted?
No — the FDA approves the laser device, not individual surgeons or clinics. Surgeon licensing and experience are separate considerations.
Is the FDA doing anything new about LASIK right now?
Yes — a 2022 draft guidance proposes a patient decision checklist covering candidacy, expectations, and long-term risks. It’s still pending, not yet finalized.
Can LASIK actually cause blindness?
Genuinely vision-threatening outcomes are rare in the published data — 1 case of significant vision loss across 574 FDA study participants.
Is dry eye a long-term risk after LASIK?
It’s common in the first few months — up to 30% of previously symptom-free patients developed new dry eye symptoms — though it typically improves as corneal nerves heal.
